Royce & Associates’s Adient ADNT Stock Holding History

Royce & Associates’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30,099	Closed	-$608K	–	749
2026 Q1	$608K	Hold	30,099	–	–	0.01%	682
2025 Q4	$577K	Hold	30,099	–	–	0.01%	697
2025 Q3	$725K	Hold	30,099	–	–	0.01%	690
2025 Q2	$586K	Buy	+30,099	New	+$445K	0.01%	706
2024 Q2	–	Sell	-206,156	Closed	-$6.79M	–	869
2024 Q1	$6.79M	Sell	206,156 -30,380	-13%	-$1.03M	0.06%	432
2023 Q4	$8.6M	Buy	236,536 +3,900	+2%	+$134K	0.08%	356
2023 Q3	$8.54M	Sell	232,636 -2,164	-0.9%	-$86.2K	0.09%	332
2023 Q2	$9M	Sell	234,800 -10,900	-4%	-$403K	0.09%	336
2023 Q1	$10.1M	Buy	245,700 +16,100	+7%	+$672K	0.1%	306
2022 Q4	$7.96M	Buy	229,600 +9,700	+4%	+$339K	0.08%	357
2022 Q3	$6.1M	Buy	219,900 +85,700	+64%	+$2.78M	0.07%	403
2022 Q2	$3.98M	Buy	134,200 +9,200	+7%	+$309K	0.04%	541
2022 Q1	$5.1M	Buy	+125,000	New	+$5.37M	0.04%	541

Other funds holding ADNT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

HHAM

HITE Hedge Asset Management Braintree, Massachusetts $1.83B AUM 34.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royce & Associates's ADNT Position: Q2 2026 in Review

Royce & Associates sold out of Adient (ADNT) in Q2 2026, closing a stake of 30,099 shares — an estimated $608K sold.

Royce & Associates first reported a position in ADNT in Q1 2022 and held it in 13 quarters. The position peaked at $10.1M in Q1 2023. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

Royce & Associates reported no remaining Adient position as of Q2 2026 after selling out during the quarter.
Royce & Associates sold 30,099 Adient shares in Q2 2026, an estimated $608K.
Royce & Associates first reported a position in Adient in Q1 2022 and held it in 13 quarters.
Royce & Associates's Adient position peaked at $10.1M in Q1 2023.
313 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.